Inger Björk Ragnarsdóttir

PhD student at Department of Women's and Children's Health; Clinical Obstetrics

E-mail:: inger.bjork_ragnardottir@uu.se
Visiting address:: MTC-huset, Dag Hammarskjölds väg 14B, 1 tr
752 37 Uppsala
Postal address:: Akademiska sjukhuset
751 85 UPPSALA

Download contact information for Inger Björk Ragnarsdóttir at Department of Women's and Children's Health; Clinical Obstetrics

Publications

Recent publications

Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study

Björk Ragnarsdóttir, Inger; Akhter, Tansim; Junus, Katja; Lindström, Linda et al.

Part of American Journal of Hypertension, p. 523-530, 2024
- DOI for Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study
- Download full text (pdf) of Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study
Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.

Junus, Katja; Björk Ragnarsdóttir, Inger; Nordlöf-Callbo, Paliz; Bergman, Lina et al.

Part of Scientific Reports, 2022
- DOI for Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.
- Download full text (pdf) of Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.

All publications

Articles in journal

Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study

Björk Ragnarsdóttir, Inger; Akhter, Tansim; Junus, Katja; Lindström, Linda et al.

Part of American Journal of Hypertension, p. 523-530, 2024
- DOI for Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study
- Download full text (pdf) of Does Developing Interpregnancy Hypertension Affect the Recurrence Risk of Preeclampsia?: A Population-Based Cohort Study
Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.

Junus, Katja; Björk Ragnarsdóttir, Inger; Nordlöf-Callbo, Paliz; Bergman, Lina et al.

Part of Scientific Reports, 2022
- DOI for Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.
- Download full text (pdf) of Elevated mid-pregnancy plasma levels of angiotensin-converting enzyme 2 in women prior to the development of preeclampsia.